Search Within

Clifford Hudis

Formats
  1. Journal Article (484)
  2. Meeting Abstract (393)
  3. Book Section (15)
  4. Conference Paper (10)
  5. Book Whole (2)
  6. Guidelines (1)
  7. Review (1)
Groups
  1. Breast Medicine Service (906)
  2. Department of Medicine (906)
  3. Solid Tumor Oncology Division (906)
  4. Survivorship Research (906)
  5. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (318)
  6. Epidemiology and Biostatistics (242)

More Groups

People
  1. Larry Norton (293)
  2. Sujata Patil (141)
  3. Andrew Seidman (116)
  4. Chau Dang (111)
  5. Maura Dickler (102)
  6. Tiffany Traina (95)

More People

Years
  1. 2025 (2)
  2. 2023 (1)
  3. 2022 (2)
  4. 2021 (4)
  5. 2020 (5)
  6. 2019 (9)

More Years

Publications
  1. Journal of Clinical Oncology (246)
  2. Cancer Research (108)
  3. Breast Cancer Research and Treatment (77)
  4. Clinical Cancer Research (33)
  5. Cancer (30)
  6. Annals of Oncology (29)

More Publications

Publishers
  1. American Society of Clinical Oncology (249)
  2. American Association for Cancer Research (163)
  3. Springer (100)
  4. Elsevier Inc. (84)
  5. Oxford University Press (55)
  6. Wiley Blackwell (45)

More Publishers

Results (906)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Role of taxanes in adjuvant therapy
    Journal Article

    Mùˆnster, P. N.; Hudis, C. A.
    Cancer Investigation (2000)

    Fulltext@MSK | Save
  • A pilot study of interpersonal psychotherapy by telephone with cancer patients and their partners
    Journal Article

    Donnelly, J. M.; Kornblith, A. B.; Fleishman, S.; Zuckerman, E.; Raptis, G.; Hudis, C. A.; Hamilton, N.; Payne, D.; Massie, M. J.; Norton, L.; more...
    Psycho-Oncology (2000)

    Fulltext@MSK | Save
  • The McCarthy/Swain article reviewed [Update on adjuvant chemotherapy for early breast cancer]
    Journal Article

    Hudis, C. A.
    Oncology (Norwalk) (2000)

    Fulltext@MSK | Save
  • Effect of adjuvant tamoxifen on the endometrium in women with breast cancer: A prospective study using office endometrial biopsy
    Journal Article

    Barakat, R. R.; Gilewski, T. A.; Almadrones, L.; Saigo, P. E.; Venkatraman, E.; Hudis, C.; Hoskins, W. J.
    Journal of Clinical Oncology (2000)

    Fulltext@MSK | Save
  • Breast cancer prevention: Are we making progress?
    Journal Article

    Bush, T. L.; Cummings, S. R.; Hudis, C. A.
    Contemporary Ob/Gyn (2000)

    Fulltext@MSK | Save
  • An immunotherapeutic approach to treatment of breast cancer: Focus on trastuzumab plus paclitaxel
    Journal Article

    Gilewski, T.; Seidman, A.; Norton, L.; Hudis, C.
    Cancer Chemotherapy and Pharmacology (2000)

    Fulltext@MSK | Save
  • Phase II trial of weekly 1-hour taxol and herceptin for metastatic breast cancer: Toward further exploitation of proven synergistic antitumor activity
    Meeting Abstract

    Seidman, A. D.; Fornier, M.; Hudis, C.; Theodoulou, M.; Surbone, A.; Moynahan, M. E.; Currie, V.; Moasser, M.; Chin, J.; Bach, A.; more...
    Cancer Investigation (1999)

    Fulltext@MSK | Save
  • Herceptin in the treatment of advanced breast cancer
    Meeting Abstract

    Norton, L.; Baselga, J.; Seidman, A.; Hudis, C.; Theodoulou, M.
    Cancer Investigation (1999)

    Fulltext@MSK | Save
  • Preliminary results of a phase 1 study of a third-generation selective estrogen receptor modulator (SERM3, LY353381.HC1) in refractory, metastatic breast cancer
    Meeting Abstract

    Hudis, C.; Buzdar, A.; Munster, P.; Booser, D.; Seidman, A.; Theriault, R.; Moasser, M.; Frye, D.; Surbone, A.; Major, M.; more...
    Cancer Investigation (1999)

    Fulltext@MSK | Save
  • Phase II study of weekly intravenous trastuzumab (Herceptin) in patients with HER2/neu-overexpressing metastatic breast cancer
    Journal Article

    Baselga, J.; Tripathy, D.; Mendelsohn, J.; Baughman, S.; Benz, C. C.; Dantis, L.; Sklarin, N. T.; Seidman, A. D.; Hudis, C. A.; Moore, J.; more...
    Seminars in Oncology (1999)

    Fulltext@MSK | Save